Researchers at The Institute of Cancer Research in London identified a mechanism causing breast cancer cell "hibernation" during hormone therapy, potentially leading to harder-to-treat relapses in ER+ breast cancer patients.
Researchers at The Institute of Cancer Research in London discovered a mechanism that causes some breast cancer cells to enter "hibernation" when exposed to hormone therapies, potentially leading to more difficult-to-treat relapses. However, there may be a way to target these "sleeping" cancer cells before they awaken, offering hope to patients with oestrogen receptor-positive (ER+) breast cancer, the most common form of breast cancer.
March 26, 2024
25 Articles